Addressing the barriers to implementing model based designs in dose escalation studies

Addressing the barriers to implementing model based designs in dose escalation studies

Bibliographic Details
Main Authors:	Cornelius, Victoria, Bond, Simon
Format:	Online
Language:	English
Published:	BioMed Central 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660329/

Similar Items

Dose escalation of a curcuminoid formulation
by: Lao, Christopher D, et al.
Published: (2006)

Some small sample properties of the EWOC design in dose escalation trials
by: Kinnersley, Nelson
Published: (2015)

Efficacy of Dose-Escalated Radiotherapy for Recurrent Colorectal Cancer
by: Jo, Sunmi, et al.
Published: (2016)

PK/PD modeling supports the dose-escalation decision in VIKING
by: Lovern, M, et al.
Published: (2010)

Biological modelling of the radiation dose escalation effect of regional hyperthermia in cervical cancer
by: Crezee, J., et al.
Published: (2016)

Efficiency of New Dose Escalation Designs in Dose-Finding Phase I Trials of Molecularly Targeted Agents
by: Le Tourneau, Christophe, et al.
Published: (2012)

Feasibility of extreme dose escalation for glioblastoma multiforme using 4π radiotherapy
by: Nguyen, Dan, et al.
Published: (2014)

Addressing the barriers of managing change
by: Charles, Macadam
Published: (1996)

Dose‐escalation study of tabalumab with bortezomib and dexamethasone in Japanese patients with multiple myeloma
by: Iida, Shinsuke, et al.
Published: (2016)

Phase I Dose-Escalation Study of Nimustine in Tumor-Bearing Dogs
by: TAKAHASHI, Masashi, et al.
Published: (2014)

NONVERBAL COMMUNICATION AND CONFLICT ESCALATION: AN ATTRIBUTION‐BASED MODEL
by: Tricia S., Jones, et al.
Published: (1993)

Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)
by: Keizer, Ron J., et al.
Published: (2011)

Attractor landscapes and reaction functions in escalation and de-escalation
by: Dean, G. Pruitt, et al.
Published: (2014)

Design And Development Of Seating Or Escalator For Double Storey House
by: Khairuddin , Mahalil
Published: (2008)

The Styrene Metabolite, Phenylglyoxylic Acid, Induces Striatal-Motor Toxicity in the Rat: Influence of Dose Escalation/Reduction over Time
by: Terre’Blanche, Gisella, et al.
Published: (2010)

Modelling the SCM implementation barriers
by: S. J., Gorane, et al.
Published: (2015)

Dose escalated intensity modulated radiotherapy in the treatment of cervical cancer
by: Cihoric, Nikola, et al.
Published: (2015)

Safety of a dose-escalated pre-workout supplement in recreationally active females
by: Vogel, Roxanne M, et al.
Published: (2015)

Dose-Escalated Robotic SBRT for Stage I–II Prostate Cancer
by: Meier, Robert
Published: (2015)

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer
by: Terakedis, Breanne, et al.
Published: (2011)

Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy
by: Skinner, Heath D, et al.
Published: (2013)

What does a modified-Fibonacci dose-escalation actually correspond to?
by: Penel, Nicolas, et al.
Published: (2012)

A dose escalation trial for the combination of erlotinib and sirolimus for recurrent malignant gliomas
by: Nghiemphu, Phioanh Leia, et al.
Published: (2012)

Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS
by: Tjalf Ziemssen, et al.
Published: (2017-08-01)

Definitive radiotherapy dose escalation with chemotherapy for treating non-metastatic oesophageal cancer
by: Chao-Yueh Fan, et al.
Published: (2018-08-01)

Dose-Escalated Radiotherapy for the Treatment of Patients With Recurrent Colorectal Cancer
by: Kim, Hyung Jin, et al.
Published: (2016)

Oral carvedilol in escalating doses in the acute treatment of atrial fibrillation
by: Chitrapu, Ravi Venkatachelam, et al.
Published: (2014)

COMBINED RADIATION THERAPY FOR PROSTATE CANCER WITH DOSE ESCALATION BRACHYTHERAPY AND ANDROGEN DEPRIVATION
by: Auchynikau V. A., et al.
Published: (2018-09-01)

Sifalimumab, a Human Anti–Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose-Escalation Study: A Phase I Randomized, Controlled, Dose-Escalation Study
by: Petri, Michelle, et al.
Published: (2013)

A product of independent beta probabilities dose escalation design for dual-agent phase I trials
by: Mander, Adrian P, et al.
Published: (2015)

Sex Differences in Dose Escalation and Overdose Death during Chronic Opioid Therapy: A Population-Based Cohort Study
by: Kaplovitch, Eric, et al.
Published: (2015)

Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
by: Kim, Jun Won, et al.
Published: (2016)

An Outpatient, Ambulant-Design, Controlled Human Infection Model Using Escalating Doses of Salmonella Typhi Challenge Delivered in Sodium Bicarbonate Solution
by: Waddington, Claire S., et al.
Published: (2014)

DESIGN AND IMPLEMENTATION OF DYNAMIC UPDATE SYSTEM FOR GEOGRAPHICAL NAMES AND ADDRESSES
by: Y. Liu, et al.
Published: (2018-09-01)

Barriers in implementation of evidence‐based practice
by: Henna, Hasson, et al.
Published: (2011)

A conceptual framework to address barriers to knowledge management in project-based organizations
by: Peyman, Akhavan, et al.
Published: (2014)

Addressing Regulatory Software Barriers to Business Growth
by: Kularatne, Chandana, et al.
Published: (2014)

Creating communities of professionalism: addressing cultural and structural barriers
by: Joseph, Murphy
Published: (2015)

A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted olid tumours
by: Adenis, A, et al.
Published: (2013)

Kinase domain mutations and responses to dose escalation in chronic myeloid leukemia resistant to standard dose imatinib mesylate
by: Rajappa, Senthil, et al.
Published: (2013)